Kim Do Hyun, Stybayeva Gulnaz, Hwang Se Hwan
Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Eur Arch Otorhinolaryngol. 2025 Jan;282(1):37-46. doi: 10.1007/s00405-024-08885-6. Epub 2024 Aug 5.
To assess the short-term effects of topical platelet-rich plasma (PRP) injection on persistent refractory olfactory dysfunction.
A comprehensive literature search of the PubMed, SCOPUS, EMBASE, Web of Science, Google Scholar, and Cochrane databases was conducted for articles up to November 2023. The search focused on studies that compared the amelioration of olfactory dysfunction between a topical PRP treatment cohort and a control group (receiving either placebo or no treatment), along with pre- and post-treatment comparisons. Subgroup analysis of the evaluation of olfactory function was also performed.
The improvement in olfactory scores 1-3 months post-treatment (standardized mean difference = 1.5354 [95% confidence interval: 0.7992; 2.2716], I = 83.8%) was greater in the treatment group than in the control group. In the treatment group, PRP increased the threshold, discrimination, and identification (TDI) score for Sniffin' Sticks by > 5.5 (minimum clinically significant difference; mean difference = 6.1789 [3.9788; 8.3789], I = 0.0%), indicating clinically significant improvement based on verified examinations. The rate of significant improvement among patients was 0.6683 [0.5833; 0.7436] after treatment. All TDI subdomains were significantly and similarly improved after treatment.
This meta-analysis suggests that injection of PRP into the olfactory fissure or surrounding mucosal areas is an effective treatment for persistent refractory olfactory dysfunction in the short term.
评估局部注射富血小板血浆(PRP)对持续性难治性嗅觉功能障碍的短期影响。
对截至2023年11月的PubMed、SCOPUS、EMBASE、Web of Science、谷歌学术和Cochrane数据库进行全面文献检索。检索重点是比较局部PRP治疗组与对照组(接受安慰剂或不治疗)之间嗅觉功能障碍改善情况的研究,以及治疗前后的比较。还对嗅觉功能评估进行了亚组分析。
治疗后1 - 3个月,治疗组嗅觉评分的改善程度(标准化均数差 = 1.5354 [95%置信区间:0.7992;2.2716],I = 83.8%)大于对照组。在治疗组中,PRP使嗅棒测试的阈值、辨别力和识别力(TDI)评分提高了>5.5(最小临床显著差异;均数差 = 6.1789 [3.9788;8.3789],I = 0.0%),表明经验证检查有临床显著改善。治疗后患者中显著改善的比例为0.6683 [0.5833;0.7436]。治疗后所有TDI子域均有显著且相似的改善。
这项荟萃分析表明,将PRP注射到嗅裂或周围黏膜区域是短期内治疗持续性难治性嗅觉功能障碍的有效方法。